Role of performance metrics in breast screening imaging - where are we and where should we be?

S L Cohen; R G Blanks; J Jenkins; O Kearins

doi:10.1016/j.crad.2017.12.012

Role of performance metrics in breast screening imaging - where are we and where should we be?

Clin Radiol. 2018 Apr;73(4):381-388. doi: 10.1016/j.crad.2017.12.012. Epub 2018 Feb 1.

Authors

S L Cohen¹, R G Blanks², J Jenkins³, O Kearins⁴

Affiliations

¹ Screening QA Service, Public Health England, London, UK. Electronic address: [email protected].
² Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
³ Breast Screening Programme, Public Health England, London, UK.
⁴ Screening QA Service, Public Health England, London, UK.

PMID: 29395223
DOI: 10.1016/j.crad.2017.12.012

Abstract

The NHS Breast Screening Programme (NHSBSP) was started in 1988 and is a large, organised cancer screening programme. It is delivered by 80 services across England and screens over 2 million women each year. As a screening programme, it must balance the detection of cancers against possible harm to women who do not have cancer. The NHSBSP was therefore designed with detailed information gathering and performance metrics right from the start. In this review paper, we examine how performance metrics in screening mammography have improved the national screening programme and the further developments and challenges that are expected in the years to come.

Publication types

Review

MeSH terms

Breast / diagnostic imaging
Breast Neoplasms / diagnostic imaging*
Early Detection of Cancer / methods*
Early Detection of Cancer / standards*
Early Detection of Cancer / statistics & numerical data
England
Female
Humans
Mammography / methods*
Mammography / standards*
Mammography / statistics & numerical data
Sensitivity and Specificity

Grants and funding

16491/CRUK_/Cancer Research UK/United Kingdom